Investors

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

/assets/dotcom/content-app/events/banner-investors-events_20230703194346.jpg

First Quarter 2025

First quarter 2025 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.

Thursday April 24, 2025
13:00 - 14:30 CEST (7:00am – 8:30am EDT)

Discover more

Press Releases

May 1, 2025
Media Update: ATS: Sanofi showcases leadership and breadth of scientific innovation in chronic inflammatory respiratory conditions
Read the Media Update
April 30, 2025
Press Release: Annual General Meeting of April 30, 2025
Read the Press Release
April 30, 2025
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
Read the Press Release
See more press releases

Upcoming Events

13May

2025

ODDO BHF Sustainability Forum

Paris

Conferences

13May

2025

BofA US Healthcare Conference

08:00 PDT (Las Vegas)

Conferences

15May

2025

Redburn Atlantic Canada Conference

08:00 ET (Toronto)

Conferences

All our events
Karine Roblot, wearing a light green protective suit, operating steel equipment with lots of valves, gauges and tubing
Karine Roblot, Vaccine Formulation Technician, Val de Reuil, France

2024 20-F

Presenting our 2024 FORM 20-F.

See more

30th consecutive year of dividend increase

Learn more
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

Read more

Contact Our Investor Relations Team

For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00